T. Longoria Dubocq1, M. Serpa1, A. Lugo1, E. Santiago1, A. Gonzalez1, W. Mendez-Latalladi1 1University Of Puerto Rico School Of Medicine,Endocrine Surgery Section. Department Of Surgery,San Juan, Puerto Rico, USA
Introduction: Thyroid surgery has been practiced for many years by General Surgeons to treat benign and malignant disease. However, the development of new surgical sub-specialties have demonstrated that treating thyroid disease at a high volume center (HVC) improves outcomes in this kind of patients. Many studies have showed that thyroid reoperations have a higher complication rate when compared to single thyroid surgery. We studied the incidence of causes for surgery reoperation and if whether the initial surgery was performed at a low volume center (LVC) or HVC.
Methods: This is a retrospective study were we analyzed all thyroid reoperations from 2013 to 2018 at a HVC institution. HVC was defined as hospital that performed more than 100 thyroid surgeries per year and surgeons with more than 25 thyroid surgeries per year. Data from previous surgeries, and reasons for reoperation was gathered and evaluated statistically. Reoperation was defined as a patient who had thyroid surgery with previous history of thyroid surgery. Patients were also divided into two groups depending on where their first surgery took place: LVC (Group 1) or HVC (Group 2). SPSS statistical software and Pearson’s Chi-Square test used for analysis and comparison. To establish statistical significance a p-value ≤ 0.05 was utilized.
Results: We examined 786 records of which 105 (7.49%) had undergone a previous thyroid surgery. Five were excluded due to lack of information. There were 86% (86/100) females and 14% (14/100) male in our study. The most common overall reason for re-operation was completion thyroidectomy due to previous lobectomy pathology positive for cancer 35% (35/100); followed by recurrence of malignant disease 34% (34/100) overall. Reoperation for benign disease was 23% (23/100) overall. Group 1 consisted of 40% (40/100) of patients while Group 2 had 60% (60/100) of patients. In Group 1, the most common reason for reoperation was malignant disease recurrence with 47.5% (19/40). In Group 2, the incidence of malignant disease recurrence occupied 25% (15/60) of the cases which was significant when compared between the two groups (p=0.001). Group 2 most common reason for reoperation was a malignant lesion requiring completion thyroidectomy with 53.33% (32/60).
Conclusion: The most common reason for reoperative thyroid surgery was a previous lobectomy with incidental malignancy and indications for a completion thyroidectomy. When the first surgery was performed in a LVC, the most common reason for reoperation was recurrence of malignancy.